EDITORIAL article
Front. Immunol.
Sec. Autoimmune and Autoinflammatory Disorders : Autoimmune Disorders
This article is part of the Research TopicMathematical Modeling in Discovery and Analysis of Immune ResponsesView all 13 articles
Mathema'cal Modeling in Discovery and Analysis of Immune Responses
Provisionally accepted- 1University of Pittsburgh, Pittsburgh, United States
- 2Politechnika Slaska, Gliwice, Poland
- 3Uniwersytet Warszawski, Warsaw, Poland
Select one of your emails
You have multiple emails registered with Frontiers:
Notify me on publication
Please enter your email address:
If you already have an account, please login
You don't have a Frontiers account ? You can register here
Immunology is a field where such modeling may be particularly helpful, taking into account intertwined mechanisms involved in organism responses to viral or bacterial infections, autoimmune diseases, and immunotherapies. For example, mathematical models can be used by immunologists both to explore theoretical ideas such as kinetic proofreading of TCR activation, and as a tool to analyze the increasingly large and complex datasets that are now being produced. Increasingly, experimental immunologists are working closely with modelers and computer scientists to develop deeper insights into their data, and to design the next set of experiments. New machine learning and other tools can extract not only statistically significant differences between different scenarios but provide additional mechanistic insight which can then be tested experimentally. In this research topic, 12 original research articles cover many different applications of mathematical modeling to both the analysis of experimental datasets and the development of new theoretical insights. The topics covered include theoretical analyses of immune cell and antibody function, novel analysis tools for high density datasets and are applied to cancer, autoimmunity and infectious disease.Three of the articles 1-3 provide novel theoretical models to understand various aspects of antibody function and TCR binding specificity. The first 1 describes a model that addresses the fact Antibody Dependent Cellular Cytotoxicity (ADCC) and Antibody Dependent Cellular Phagocytosis (ADCP) are mediated by IgG binding to two different FcgR expressed on two different cell types. The ODE model was used to predict immune complexes binding to the ADCC-mediating FcgRIIIA or the ADPC-mediating FcgRIIA as a function of IgG, antigen and FcgR concentration. The model was further used to simulate the effect of a boost of the IgG response in a cohort of individuals in an HIV vaccine trial. Work by Kovacs et al 3 proposes the use of a thermodynamic titer by applying the Richards function as a more accurate measure of serum antibody titer. The third article 2 in this section examines the impact of feature selection techniques in enhancing predictions of peptide binding to specific TCRs. The analysis shows that using these techniques can improve the ability to predict precise peptide TCR interactions.The immune response and disease outcome to SARS-CoV-2 infection was the subject of three articles [4][5][6] . In one of these studies 4 the authors compared the immune responses to mRNA and adenovirus (AdV) vaccines. Based on data from a cohort of vaccinated health care workers a kinetic model of humoral immunity was constructed that included the dynamics of multiple immune markers. The model predicted higher levels of proliferating memory B cells in individuals receiving the mRNA vaccine and also suggested that increasing the time between the first and second vaccine doses beyond 28 days boosted the production of neutralizing antibody. In the second article 5 the levels of anti-SARS-CoV-2 antibodies were examined in a cohort of patients in Quzhou, China. The impact of infection, vaccination and hybrid immunity on the antibody titers was examined using multivariate analysis and a decision tree modeling approach. This study identified factors that can inform vaccine strategies and public health measures in the control of COVID-19 disease. Another study 6 tested different machine learning approaches to predict the risk of mortality in older patients with COVID-19 disease, based on blood markers of inflammation and hypercoagulability. Nine different machine learning models were used and the study found that the Gaussian naïve Bayes model performed the best in predicting mortality and identified five blood markers that were significantly associated with death in this cohort of 199 patients. Two studies 7,8 used mathematical modeling to study the impact of immunotherapy in two different cancer models. CAR-T cell therapy has proved efficacious in liquid hematological malignancies but has limited impact in solid tumors. The first study 8 developed mathematical models to investigate the treatment dynamics of glioblastoma with CAR-T therapy. The model incorporated important biological processes such as tumor growth, CAR-T cell proliferation, time delay of immune reaction, and resistance mechanisms. Simulations were based on existing clinical trial strategies and examined the impact of single or multiple dose approaches. Results indicated that cyclic CAR-T therapy was superior to a single dose and provided insights into the relapse dynamics and the durability of the therapeutic effect. The second article 7 examined the role tumor infiltrating (TIL) B cells in lung adenocarcinoma and the response to immunotherapy using machine learning tools to analyze pre-existing multiomic datasets. By analyzing scRNA-seq datasets the study identified a Biomarker-based Risk Index (BRI) based on 27 variables that could be used to predict outcomes in lung cancer patients. Patients with a high BRI were found to have poorer outcomes and reduced response to immune checkpoint blockade. Low BRI was associated with increased tumor infiltration of B cells, CD4+ T cells, NK cells, M2 macrophages and Treg cells. Experimental validation of these results will be needed to substantiate the use of this index. Three studies [9][10][11] examined immune parameters in patients with autoimmune disease using mathematical modeling approaches. One article 10 describes a novel pseudotemporalbased single-cell network inference algorithm, ONIDsc, designed to identify immunopathogenic mechanisms in SLE using ChIP-chip and ChIP-seq datasets from healthy controls and SLE patients. This method is based on a previous model, SINGE, and was shown to outperform SINGE and other similar models in identifying immune networks important in SLE. The method identified networks related to innate and B cell activation and identified four genes that were uniquely expressed in SLE patients. Another study 11 examined the development of a twobranch Bayesian network to analyze Raman spectroscopy data in patients with SLE, leading to improvements in diagnostic accuracy. The use of Raman spectroscopy has been limited by the challenges due to spectral overlap and challenges in identifying relevant features. The authors present a new deep learning approach that can used to accurately deconvolute Raman spectroscopy data and provide a tool for the diagnosis of SLE and to monitor disease activity. A study 9 examined the responses to TNF-a in PBMCs from healthy donors and RA patients using a single cell multi-omics Cite-seq approach. This study revealed that classical monocytes responded the most to TNF-a and this was correlated with increased expression of TNFR2. RA patients showed a more blunted response to TNF-a and this was correlated with reduced TNFR2 expression on classical monocytes.The final paper 12 in this research topic develops a mathematical framework to analyze human neutrophil differentiation states from single cell data. The study utilized datasets from single cell RNA-seq data from adult human neutrophils. These data were used to inform a novel ODE-based mathematical framework which identifies 5 different transcriptional states in circulating neutrophils from healthy individuals. The model provides a quantitative model of neutrophil transition states that can be used in samples from patients with different diseases. This research topic thus covers a wide range of topics and highlights the myriad ways that mathematical models and analysis tools are impacting the progress of immunological research. As we develop more sophisticated and multi-omic experimental methodologies there will be an increasing need for the development of more tools such as the ones described here.
Keywords: Autoimmunity, Cancer, immunology, Infectious Disease, mathematical model
Received: 04 Dec 2025; Accepted: 08 Dec 2025.
Copyright: © 2025 Morel, Smieja and Foryś. This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) or licensor are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.
* Correspondence: Penelope Anne Morel
Disclaimer: All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article or claim that may be made by its manufacturer is not guaranteed or endorsed by the publisher.